financetom
Business
financetom
/
Business
/
China's COMAC falls behind on C919 aircraft delivery targets, filings show
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's COMAC falls behind on C919 aircraft delivery targets, filings show
Sep 23, 2025 11:15 PM

(Reuters) -Chinese planemaker COMAC is falling behind on previously stated delivery targets for the production of its narrow-body C919 commercial plane, according to regulatory filings from the three airlines that fly the model.

China Eastern Airlines, Air China and China Southern were expecting 32 of the planes to be delivered this year, but as of September only five have been handed over from COMAC, according to airline financial reports and data from ch-aviation and Flightradar24.

The state-owned manufacturer has cut its own C919 production target to 25 this year from a previously stated goal of 75, Bloomberg reported on Wednesday, citing sources familiar with the matter. COMAC did not respond immediately to a request for comment.

COMAC in January said it planned to deliver 30 C919 planes and scale up annual production capacity to 50 aircraft in 2025. In March, it raised the production target up to 75, according to Chinese media reports.

COMAC is seeking to compete internationally with leading Western planemakers Airbus and Boeing ( BA ), which produce dozens of their single-aisle A320neo family and 737 MAX jets each month.

COMAC this year faced the unexpected challenge of the United States temporarily halting exports of the CFM engines it uses on the C919 between June and July as trade tensions escalated. A key vulnerability of China's jet-building programme is that major elements of the designs use foreign parts.

The C919, which lacks benchmark certifications from major Western aviation regulators, has only had orders from Chinese customers and two airlines in Brunei and Cambodia - both close allies of Beijing.

Aviation consultancy IBA said last month that COMAC's C919 production targets were ambitious and it expected "more measured growth" from the manufacturer.

IBA forecast around 18 C919s would be delivered in 2025 and 25 in 2026, rising to about 45 in 2027.

China Eastern, Air China and China Southern each ordered 100 of the jets.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Morgan Stanley questioned by US House panel over Zijin Gold IPO in Hong Kong 
Morgan Stanley questioned by US House panel over Zijin Gold IPO in Hong Kong 
Nov 13, 2025
NEW YORK (Reuters) -Morgan Stanley's ( MS ) underwriting of Zijin Gold International's Hong Kong IPO placed it and its U.S. investors at risk of regulatory, financial and reputational harm, a U.S. House of Representatives committee told the bank on Thursday.  Zijin Gold is a subsidiary of Zijin Mining Group, a global mining company based in China that is on a...
Australian AI company Firmus to raise $325 million to accelerate AI infrastructure rollout
Australian AI company Firmus to raise $325 million to accelerate AI infrastructure rollout
Nov 13, 2025
Nov 14 (Reuters) - Australia's Firmus announced on Friday an equity raise of A$500 million ($324.90 million) as the artificial intelligence company and potential IPO candidate looks to accelerate development of Project Southgate, its AI infrastructure initiative. The move comes as global firms push for more investment into infrastructure necessary to compute artificial intelligence technologies amid growing demand for AI-related...
BRIEF-Merck Nearing Deal For Flu Treatment Start-Up Cidara - FT
BRIEF-Merck Nearing Deal For Flu Treatment Start-Up Cidara - FT
Nov 13, 2025
Nov 13 (Reuters) - * MERCK NEARING DEAL FOR FLU TREATMENT START-UP CIDARA - FT * A DEAL VALUING CIDARA AT A PREMIUM TO ITS $3.3BN MARKET CAPITALISATION COULD BE ANNOUNCED AS SOON AS FRIDAY - FT Source text: https://tinyurl.com/3z54juzh ...
Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race
Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race
Nov 13, 2025
(Reuters) -Mikael Dolsten, Pfizer's ( PFE ) former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday. Dolsten, who led Pfizer's ( PFE ) R&D operations until 2024, informed Novo that he would not seek election at Friday's extraordinary general meeting. He has previously held senior R&D roles...
Copyright 2023-2026 - www.financetom.com All Rights Reserved